Abcuro, Inc.
Abcuro, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis | inclusion body myositis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 / Phase 3 | 2025-07-28 | NCT06450886 |